Agg-CLNP synergized with abatacept to delay RA-related inflammation and with dexamethasone to prevent flare-ups following ...

A bacteria-based cancer therapy has been engineered that eradicates tumors in immunocompromised mice—no immune cells required.

Ocugen says it is on track to reshape the market for gene therapies against eye disorders over the next three years, by ...

In addition to cell line development, CHO Plus partnered to scale up Avid Bioservices' mAb production to meet industrial scale requirements.